Key trends include strategic CDMO partnerships and a shift to in vivo administration, enhancing accessibility and innovation ...

To discover more about Nature’s Fynd, visit. To learn about their remarkable nutritional fungi protein and fermentation ...

NHS Scotland has approved a one-time CRISPR gene therapy for severe sickle cell disease, offering durable reduction in vaso-occlusive crises for eligible patients.

A "gene silencer" (technically known as small interfering RNA, or siRNA), locally delivered by nanoparticles embedded in an ...

While GLP-1 (glucagon-like peptide-1) class obesity treatments like ‘Wegovy’ and ‘Mounjaro’ have gained immense popularity, ...

ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, today announced the ...

Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...

Reducing manual touchpoints is an important part of supporting more consistent and scalable manufacturing processes.

Ace Therapeutics announces its preclinical ophthalmic drug development services to help expedite the discovery of ...

Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model ...

Few companies stand better poised than Beam Therapeutics to reap the first fruits of the FDA’s promised flexibility toward cell and gene therapies. | Riding a regulatory win for its base editing ...

Often questions about the safety and efficacy of vaccines go unanswered because they're raised within their own circle. | Opinions ...